Dr. Godwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 East 70th Street
Weill Cornell Internal Medicine Associates
New York, NY 10021Phone+1 212-746-4749
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
The Warren Alpert Medical School of Brown UniversityClass of 2011
Certifications & Licensure
PA State Medical License 2014 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 94 citationsNivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancerJames Luke Godwin, Shuchie Jaggi, Imali Sirisena, Pankaj Sharda, Ajay D. Rao
Journal for Immunotherapy of Cancer. 2017-05-16 - 12 citationsImmune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?Chethan Ramamurthy, James Luke Godwin, Hossein Borghaei
Current Treatment Options in Oncology. 2017-05-22 - 154 citationsLong-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelia...Jacqueline Vuky, Arjun Vasant Balar, Daniel Castellano, Peter H. O'Donnell, Petros Grivas
Journal of Clinical Oncology. 2020-06-17
Press Mentions
Clinical Challenge: Immunotherapy-Related Diabetes in Cancer PatientsJune 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
